Lactate Arterial-Central Venous Gradient among COVID-19 Patients in ICU: A Potential Tool in the Clinical Practice

<div>Delta a-cv lactate before (<i>T</i><sub>0</sub>) and after (<i>T</i><sub>1</sub>) canakinumab administration in 13 patients. Black horizontal line inside the boxes: median. Box height: interquartile range. Grey area: normal Delta a-cv lactate values (≤0).</div>

Critical Care Research and Practice

fig1

Figure 1

Figure 1: Lactate Arterial-Central Venous Gradient among COVID-19 Patients in ICU: A Potential Tool in the Clinical Practice 